Supportive Care
Conditions
Brief summary
To pilot test the feasibility, usability, and preliminary efficacy of the D-SCAN mobile application in cancer patients and caregivers at Duke.
Detailed description
D-SCAN, a digital patient navigator service in the form of a mobile application (app), has been designed at Duke, with feedback from Duke Cancer Institute (DCI) patients, caregivers and clinicians (screenshots in Appendix A).3 Its purpose is to facilitate awareness of available Cancer Patient Support Program (CPSP) services at Duke, and to also help patients recognize their unmet symptom management needs by answering questions from the Edmonton Symptom Assessment Scale (ESAS). This novel electronic system helps to connect patients and their loved ones with existing resources tailored to their unique situations, ensuring that no supportive care needs go unaddressed, thus improving patients' lives and their cancer care. This protocol aims to assess the feasibility, usability, and preliminary efficacy of the D-SCAN mobile application. The app data, along with quantitative and qualitative feedback obtained during the pilot, will inform future development and design of a subsequent efficacy trial.
Interventions
DEVICED-SCAN
Subjects will receive a digital patient navigator service in the form of a mobile application (app), which has been designed at Duke, with feedback from Duke Cancer Institute (DCI) patients, caregivers and clinicians. Its purpose is to facilitate awareness of available Cancer Patient Support Program (CPSP) services at Duke, and to also help patients recognize their unmet symptom management needs. Subjects receiving the D-SCAN mobile app will also complete a survey every week within the app. The first 15 patients and 5 caregivers randomized into the intervention arm (those receiving the app) will also be asked to participate in a qualitative interview assessment at week 12, +/- 3 weeks
Sponsors
AstraZeneca
Duke University
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients who are at least age 18 * Patients who have the capacity to give consent * Patients with advanced cancer who have initiated treatment at the DCI in the last 12 weeks * Caregivers over the age of 18 caring for either enrolled or not enrolled patients with advanced cancer who have initiated treatment at the DCI in the last 12 weeks
Exclusion criteria
* Patients who are too ill to participate (per clinician discretion) * Patients not able to read or understand English
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of enrolled patients complete at least 3 of the 12 symptom surveys over the study duration | 12 weeks |
| Number of patients who complete the exit survey | 12 weeks |
| Number of patients who return the phone | 12 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Number of content views | 12 weeks |
| Frequency of use | 12 weeks |
| Number of actions taken | 12 weeks |
| Duration of use | 12 weeks |
| Session Length | 12 weeks |
Countries
United States
Outcome results
None listed